Free Preparation Discussions
MENU
SCDM CCDM Exam - Topic 4 Question 9 Discussion
Topic #: 4
Which document describes what study subjects expect with respect to data disclosure during and after a study?
The Informed Consent Form (ICF) is the document that explicitly describes what study subjects can expect regarding data disclosure, privacy, and confidentiality during and after participation in a clinical trial. According to ICH E6 (R2) Good Clinical Practice and FDA Human Subject Protection Regulations (21 CFR Parts 50 and 56), participants must be fully informed about how their personal and clinical data will be collected, used, stored, and shared --- both during the study and in any subsequent data-sharing or publication activities.
The GCDMP reiterates that clinical data managers must ensure that all data handling practices align with the privacy commitments made in the ICF. This includes compliance with data protection regulations such as HIPAA (in the U.S.) and GDPR (in the EU). The ICF defines the permissible scope of data use, ensuring ethical management and subject protection.
Documents like the protocol or data sharing plan may outline procedures and responsibilities but do not directly inform participants of their rights and data use expectations. Only the ICF is designed for that ethical communication purpose.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Ethics, Privacy, and Data Security
ICH E6 (R2) Good Clinical Practice, Sections 4.8.10 & 4.8.12
FDA 21 CFR Part 50 -- Protection of Human Subjects, Informed Consent Requirements
Lera
24 hours agoEmerson
6 days agoLinsey
11 days agoLino
16 days agoJacquelyne
22 days agoDaryl
27 days agoBenedict
2 months agoJanella
2 months agoChristene
2 months agoDesmond
2 months agoLilli
2 months agoGenevive
2 months agoSherly
3 months agoJovita
3 months agoStanton
3 months agoGlendora
3 months agoJin
3 months agoLigia
3 months ago